<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Cibinetide</title><link>https://peptidescanner.com/peptides/cibinetide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Cibinetide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/cibinetide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT02039687</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02039687-cibinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02039687-cibinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#clinicaltrials-gov-nct02039687-cibinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-04-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ARA 290 for treatment of small fiber neuropathy in sarcoidosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-24555851-cibinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-24555851-cibinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#pubmed-pmid-24555851-cibinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-05-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26774587-cibinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26774587-cibinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#pubmed-pmid-26774587-cibinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-05-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32674280-cibinetide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32674280-cibinetide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/cibinetide.json#pubmed-pmid-32674280-cibinetide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-09-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
